Ideas to action: independent research for global prosperity
Refugees and the Education of Host Populations
February 08, 2024
The Responsibility of My Country in an Unjust Global System
February 02, 2024
Developing an Omni-Channel Deployment Strategy for COVID-19 Oral Antivirals
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Testimony on Modernizing Development Assistance
December 13, 2022
On December 13th 2022, CGD Senior Fellow Prashant Yadav appeared before the House Foreign Affairs Subcommittee on International Development, International Organizations, and Global Corporate Social Impact at a hearing titled “Modernizing International Development Assistance: Opportunities and Challe...
A Global Development Paradigm for a World in Crisis
November 08, 2022
This paper explores how and whether responses to COVID-19, particularly from non-DAC actors, have deepened the transition from an “international” to a “global” development paradigm, and it considers implications for the future of development cooperation.
Rapid and Equitable Access to Medical Countermeasures: Lessons, Landscape, and Near-Term Recommendations
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
Policy Actions for the US Government to Accelerate Access to Oral Antivirals for COVID-19 in Low- and Middle-Income Countries
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
Development Effectiveness in the “New Normal”: What Do the Changing Roles and Purposes of ODA Mean for the Effectiveness Agenda?
March 31, 2022
This paper explores how the roles and purposes of official development assistance (ODA) are changing and what these shifts mean for the future of the development effectiveness agenda. Using data obtained through a survey of officials working in development agencies and partner countries, this paper ...
Expanding Emergency Vaccine Manufacturing Capacity in Latin America and the Caribbean
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...